UK markets closed

Cue Health Inc. (HLTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1107-0.0074 (-6.27%)
As of 12:18PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1181
Open0.1050
Bid0.1021 x 400
Ask0.1090 x 300
Day's range0.1000 - 0.1150
52-week range0.0900 - 0.8350
Volume9,420,820
Avg. volume2,858,214
Market cap17.611M
Beta (5Y monthly)1.30
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)

    SAN DIEGO, May 14, 2024--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.

  • Business Wire

    Cue Health to Announce First Quarter Financial Results

    SAN DIEGO, April 29, 2024--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call.

  • Business Wire

    Cue Health Announces Strategic Actions to Position Company for Next Stage

    SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage: